Skip to main content

Table 4 Detailed breakdown of direct medical cost components (median, IQR), in 2022 US dollars

From: Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study

Cost components

Outpatients

Inpatients at RD

ICU

All

(N = 210)

RSV positive

(n = 21)

RSV negative

(n = 189)

p-value**

All

(N = 318)

RSV positive

(n = 84)

RSV negative

(n = 234)

p-value**

All RSV negative***

(n = 8)

Total direct medical costs

22 (13–32)

26 (16–32)

21 (13–32)

0.35

84 (50–135)

68 (47–102)

91 (59–153)

0.001

1996 (937–3786)

Medication costs

15 (9–20)

15 (8–18)

15 (9–20)

0.46

9 (4–19)

10 (4–21)

9 (5–19)

0.85

114 (20–678)

 Antibiotics

3 (2–5)

2 (1–4)

3 (2–5)

0.06

2 (1–4)

1 (1–3)

2 (1–5)

0.003

82 (2–705)

 Corticosteroids

1 (0–1)

0 (0–0)

1 (0–1)

0.16

0 (0–0)

0 (0–1)

0 (0–0)

0.33

0 (0–17)

 Bronchodilator oral

1 (1–1)

1 (1–1)

1 (1–1)

0.16

1 (1–1)

1 (0–1)

1 (1–1)

0.95

0 (0–0)

 Bronchodilator inhalation

1 (1–3)

2 (1–3)

1 (1–3)

0.94

5 (2–18)

11 (2–18)

4 (2–17)

0.48

7 (2–13)

 Other drugs

4 (3–6)

4 (3–5)

4 (3–7)

0.25

2 (2–4)

2 (2–3)

2 (2–4)

0.04

52 (11–367)

Laboratory costs

0 (0–2)

0 (0–2)

0 (0–2)

0.88

2 (2–13)

2 (0–3)

4 (2–17)

< 0.001

193 (64–359)

Imaging costs

3 (3–5)

3 (3–3)

3 (3–5)

0.85

6 (3–16)

3 (3–12)

6 (3–16)

0.03

28 (10–85)

 Chest X-ray

3 (3–3)

3 (3–3)

3 (3–3)

0.80

3 (3–6)

3 (3–3)

3 (3–6)

0.37

6 (4–11)

 Echocardiogram

9 (9–9)

9 (9–9)

9 (9–9)

N/A

7 (1–12)

0 (0–0)

7 (1–12)

N/A

3 (3–3)

 Ultrasound

2 (2–9)

2 (2–2)

2 (2–9)

0.43

13 (2–13)

2 (2–4)

13 (4–13)

< 0.001

8 (3–10)

Procedure & service costs

6 (3–11)

8 (4–13)

6 (3–11)

0.14

49 (24–71)

29 (19–58)

50 (29–88)

< 0.001

1,356 (524–2468)

Consultation costs

3 (2–4)

2 (2–3)

3 (2–4)

0.20

3 (2–6)

3 (2–6)

3 (2–5)

0.67

4 (2–6)

Miscellaneous costs*

8 (1–13)

0 (0–0)

8 (1–3)

N/A

13 (6–23)

12 (6–23)

13 (6–23)

0.31

204 (120–332)

  1. *Miscellaneous costs include medical consumables such as syringes, gloves, and soap
  2. **Mann–Whitney U p-value comparing between the costs associated with RSV and those associated with no RSV
  3. ***No ICU cases were identified as RSV positive
  4. ICU: intensive care unit; IQR: interquartile range; RD: Respiratory Department; RSV: respiratory syncytial virus; N/A: not applicable